Treatment of ankylosing spondylitis with co-amoxiclav.


This article presents the efficacy of co-amoxiclav in two patients with ankylosing spondylitis. Both patients were administered oral co-amoxiclav for 7 days. The primary efficacy variable was the ankylosing spondylitis activity index. Secondary outcome measures were the ankylosing spondylitis functional index and spinal mobility. We detected a marked… (More)
DOI: 10.1111/1440-1681.12952


  • Presentations referencing similar topics